Home > Products > Antibodies > Flow Cytometry (FACS) Antibodies

Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (SSS-23) (HW338207)

Datasheet Share product Copy info

Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (SSS-23)

Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (SSS-23)

Price(USD): $

Spec:

50ug
100ug

Number:

Contact us

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.	HW338207
Description	Anti-Human CD309/KDR/VEGFR-2 Antibody (SSS-23) [SSS-23] (HW338207) is a human monoclonal antibody detecting VEGFR-2 in FCM. Suitable for Human. Highlights ●Flow Cytometry — Validated for flow cytometry applications.
Species reactivity	Human
Applications	FCM
Host species	Human
Isotype	IgG1, kappa
Clone ID	SSS-23
Clonality	Monoclonal
Target	FLK-1, Kinase insert domain receptor, VEGFR2, Fetal liver kinase 1, CD309, Vascular endothelial growth factor receptor 2, Protein-tyrosine kinase receptor flk-1, FLK1, VEGFR-2, KDR
Endotoxin level	Please contact with the lab for this information.
Purity	>95% as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	P35968
Form	Liquid
Storage buffer	0.01M PBS, pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Background	Vascular endothelial growth factor receptor 2 (CD309/VEGFR-2) is a ~151 kDa protein. Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis. Promotes proliferation, survival, migration and differentiation of endothelial cells. Promotes reorganization of the actin cytoskeleton. Isoforms lacking a transmembrane domain, such as isoform 2 and isoform 3, may function as decoy receptors for VEGFA, VEGFC and/or VEGFD. CD309 is the therapeutic target of ramucirumab (Cyramza).
Note	For research use only.

Images

SDS-PAGE

SDS-PAGE for Anti-Human CD309/KDR/VEGFR-2 Antibody (SSS-23)

References

Datasheet

Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (SSS-23).pdf

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

=

Concentration

×

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

×

V₁ (Stock Vol.)

=

Working Solution

C₂ (Working Conc.)

×

V₂ (Working Vol.)

Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list

Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (SSS-23)